Patient groups | Included N = 75 | Remission N = 23 | LTR N = 16 | Relapse N = 52 | Early Relapse N = 9 |
---|---|---|---|---|---|
Age med (IQR) | 46 (38–55) | 51 (39–56) | 41 (26–55) | 46 (37–54) | 46 (29–56) |
Sex Female/Male | 29/46 | 9/14 | 8/8 | 20/32 | 4/5 |
Colonic area R/L/E | 10/30/35 | 4/9/10 | 1/9/6 | 6/21/25 | 0/5/4 |
UCDAI score med (Range) | 0 (0–4) | 0 (0–1) | 0 (0–1) | 0 (0–4) | 0 (0–1) |
Observation time (months) med (IQR) | 121 (100–137) | 96 (74–112) | 95 (77–113) | 94 (40–122) | 4 (4–6) |
Medication | |||||
IFX | 15 | 0 | 0 | 15 | 0 |
5-ASA | 55 | 19 | 13 | 23 | 9 |
AZA/MTX | 30 | 7 | 0 | 23 | 4 |
Steroids | 4 | 0 | 0 | 4 | 0 |